Tilray | TRLY - 债务

股票价格

8.50

每天变化

0.07 0.83%

每月一次

-5.24%

每年

1,187.88%

Q2 预测

9.04

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 6.42B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	债务	更改		日
Acasti Pharma	USD 0		0	2024-09
Akebia Therapeutics	USD 46.51M		7.82M	2025-03
Alaunos Therapeutics	USD 10.99M		5.78M	2023-03
Aurora Cannabis	CAD 100.34M		1.29M	2025-09
Avita Medical	AUD 46.05M		1.46M	2025-12
Canopy Growth	CAD 259.33M		68.47M	2025-09
Cronos Group	USD 1.74M		269K	2025-09
Dianthus Therapeutics	USD 1.28M		45K	2025-09
Divis Laboratories Ltd	INR 40M		40M	2025-03
Ionis Pharmaceuticals	USD 2.34B		9.5M	2026-03
IQVIA Holdings	USD 15.72B		767M	2025-12
Knight Therapeutics	CAD 77.91M		28.33M	2025-12
Moderna	USD 734M		7M	2025-09
Organon & Co	USD 8.64B		184M	2025-12
Revvity	USD 3.37B		5.86M	2025-09
Tectonic Therapeutic	USD 876K		115K	2024-12
Tilray	USD 640.95M		35.17M	2022-06
Viatris	USD 14.41B		25.6M	2025-12
Xeris Pharmaceuticals	USD 257.65M		431K	2025-09